Holupathirage K Caldera, MD
Family Practice · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 16 years
- Graduated 2010
Offices
1 location · Saint Agnes Medical Foundation · 161 clinicians in this group
Hospitals listed: Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Caldera’s office at (559) 450-2630 to ask if they take your plan before you enroll.
California Medical Board record
Licence A179254 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · University of Melbourne Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
- American Board of Family Medicine - Sports Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 72.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$32,128
Medicare paid this office $32,128 for 159 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 95 | $12,913 | $102 |
| New patient visit (45+ min) | 54 | $6,899 | $128 |
| Short return visit (20+ min) | 40 | $3,020 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,776 | $132 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,863 | $58 |
See all 8 services
| Return visit (30+ min) | 95 | $12,913 | $102 |
| New patient visit (45+ min) | 54 | $6,899 | $128 |
| Short return visit (20+ min) | 40 | $3,020 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,776 | $132 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,863 | $58 |
| Influenza vaccine split virus, preservative free | 12 | $982 | $82 |
| Administration of influenza virus vaccine | 12 | $395 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $173 | None |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 18 | 47 | 32 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
159 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 14% · Women 67% · Also on Medicaid 30% · Health risk score 1.14. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 35% · Coronary heart disease 35% · Depression 26% · Chronic kidney disease 25% · Cancer 21% · Atrial fibrillation 16% · Heart failure 15% · COPD 14% · Dementia 8%.
The office billed $81,206, Medicare allowed $39,501 and paid $32,128; for 1,128 services of 33 kinds; $2,794 of it was for drugs given in the office and $29,334 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 159 | 1,128 | 74 | 1.14 | $81,206 | $32,128 |
| 2023 | 274 | 906 | 73 | 1.28 | $96,810 | $30,914 |
| 2022 | 80 | 277 | 75 | 1.17 | $24,182 | $9,909 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 153 | $10,604 | $56 |
| Return visit (30+ min) | 62 | $6,672 | $83 |
| New patient visit (45+ min) | 63 | $5,785 | $92 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,045 | $44 |
| New patient visit (30+ min) | 20 | $1,444 | $72 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 15 | $519 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $225 | None |
| Insertion of needle into vein for collection of blood sample | 15 | $126 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 12 | $91 | $8 |
| Urinalysis, manual test | 21 | $72 | $3 |
2022: 5 services
| New patient visit (45+ min) | 22 | $2,989 | $136 |
| Short return visit (20+ min) | 39 | $2,861 | $70 |
| Return visit (30+ min) | 15 | $1,618 | $101 |
| Aspiration and/or injection of fluid from large joint | 17 | $957 | $53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $113 | None |
Medicaid work
$0 in 2024
Medicaid paid $0 for 108 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 32 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| Short return visit (20+ min) | 15 | $0 |
| Return visit (30+ min) | 48 | $0 |
| 2024 | 108 | 4 | 27 | $0 |
| 2023 | 1,482 | 9 | 167 | $3,992 |
| 2022 | 229 | 6 | 71 | $515 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 744 | $1,413 |
| New patient visit (45+ min) | 161 | $1,148 |
| New patient visit (30+ min) | 89 | $870 |
| Return visit (30+ min) | 115 | $276 |
| SARSCOV CORONAVIRUS AG IA | 107 | $247 |
| Arthrocentesis and injection of knee joint | 90 | $21 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 73 | $17 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 91 | $0 |
2022
| Short return visit (20+ min) | 95 | $227 |
| New patient visit (45+ min) | 42 | $128 |
| New patient visit (30+ min) | 14 | $116 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $44 |
| Arthrocentesis and injection of knee joint | 31 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 15 | $0 |
Drugs they prescribed that Part D paid
$25,681
Pharmacies billed $25,681 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (18 of 316) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
270 generic and fewer than 11 brand-name prescriptions · $25,681 in drug cost · 24 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levothyroxine | 17 | $799 | $47 |
| Gabapentin | 23 | $404 | $18 |
| Amlodipine Besylate | 11 | $39 | $4 |
Year by year
| 2024 | 316 | 124 | 6% (18) | None | $25,681 |
| 2023 | 162 | 96 | None | None | $7,057 |
| 2022 | 166 | 45 | None | None | $15,281 |
| 2021 | 135 | 19 | 0% (0) | 13% | $12,717 |
| 2020 | 88 | 14 | 0% (0) | 17% | $9,177 |
| 2019 | 24 | None | 0% (0) | 54% | $6,726 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ipratropium | 18 | $525 | $29 |
| Diclofenac | 14 | $433 | $31 |
| Fluticasone Propionate | 16 | $170 | $11 |
2022: 3 drugs
| Levothyroxine | 19 | $278 | $15 |
| Atorvastatin | 18 | $180 | $10 |
| Fluticasone Propionate | 11 | $116 | $11 |
2021: 3 drugs
| Atorvastatin | 16 | $196 | $12 |
| Lisinopril | 11 | $62 | $6 |
| Amlodipine Besylate | 15 | $30 | $2 |
Money from drug and device companies
$589 in 2025
| 2025 | 10 | 33 | None | $589 |
| 2024 | 7 | 12 | None | $255 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $226 | 11 payments
|
| Lilly USA | Jardiance | $91 | 4 payments
|
| Novo Nordisk | Wegovy | $66 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $56 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $38 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $35 | 1 payment
|
See all 28 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-13 | Farxiga | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-06 | Airsupra | $17 |
| GlaxoSmithKline | Meals · 2025-11-03 | Trelegy Ellipta | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-30 | Jardiance | $19 |
| Abbvie | Meals · 2025-10-23 | Qulipta | $22 |
| GlaxoSmithKline | Meals · 2025-10-02 | Trelegy Ellipta | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-17 | Farxiga | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-27 | Airsupra | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-20 | Jardiance | $19 |
| Trice Medical | Meals · 2025-08-19 | None | $14 |
| Lilly USA | Meals · 2025-08-05 | Jardiance | $24 |
| Novo Nordisk | Meals · 2025-07-30 | Wegovy | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-16 | Farxiga | $19 |
| GlaxoSmithKline | Meals · 2025-07-15 | Trelegy Ellipta | $18 |
| Lilly USA | Meals · 2025-07-01 | Jardiance | $20 |
| Lilly USA | Meals · 2025-06-05 | Jardiance | $24 |
| Novo Nordisk | Meals · 2025-05-21 | Wegovy | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-15 | Farxiga | $16 |
| Lilly USA | Meals · 2025-05-07 | Jardiance | $24 |
| Radius Health | Meals · 2025-04-23 | None | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-16 | Farxiga | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-02 | Airsupra | $16 |
| Novo Nordisk | Meals · 2025-03-17 | Wegovy | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-13 | Farxiga | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-06 | Breztri | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-05 | Breztri | $15 |
| Esperion Therapeutics | Meals · 2025-02-19 | Nexletol | $22 |
| Exact Sciences | Meals · 2025-01-23 | Cologuard Collection Kit | $35 |
See earlier years (2024)
2024: $255
| AstraZeneca Pharmaceuticals LP | Farxiga | $80 | 4 payments
|
| Lilly USA | Jardiance | $45 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $42 | 2 payments
|
| Esperion Therapeutics | Nexletol | $24 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $22 | 1 payment
|
| Novo Nordisk | Ozempic | $22 | 1 payment
|
| GlaxoSmithKline | Shingrix | $19 | 1 payment
|
Professional record
- NPI
- 1467915082
- Licence
- CA A179254California A179254: Current · expires 2028-08-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X); Family medicine (207Q00000X)
- Mailing address
- 1111 E Spruce Ave Ste 431, Fresno, CA, 93720
- NPI first listed
- 2019-04-10
- NPI last updated
- 2025-06-02
- NPI record certified
- 2025-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1510 E Herndon Ave Ste 230, Fresno, CA, 93720